| Company Name: |
Alinda Chemical Ltd.
|
| Tel: |
+7 (495) 672-17-08 |
| Email: |
sale@alinda.ru |
| Products Intro: |
CAS:438618-32-7
Package:1mg Remarks:C20H30N2OS
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Glucagon Receptor Antagonist I
CAS:438618-32-7
Purity:99% Package:1G;10G;100G Remarks:Glucagon receptor antagonist I is a potent and competitive antagonist of the glucagon receptor (GCGR) with an IC50 value of 181 nM.
|
| Company Name: |
Shanghai EFE Biological Technology Co., Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
info@efebio.com |
| Products Intro: |
Product Name:Glucagon Receptor Antagonist I
CAS:438618-32-7
Purity:99% (HPLC) Package:500μg;1mg;5mg
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Glucagon Receptor Antagonist I
CAS:438618-32-7
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
|
| | Glucagon Receptor Antagonist I Basic information |
| Product Name: | Glucagon Receptor Antagonist I | | Synonyms: | Glucagon Receptor Antagonist I;N-[3-cyano-6-(2-methylbutan-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-2-ethylbutanamide;Butanamide, N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-2-ethyl-;hGCGR Antagonist | | CAS: | 438618-32-7 | | MF: | C20H30N2OS | | MW: | 346.53 | | EINECS: | | | Product Categories: | | | Mol File: | 438618-32-7.mol |  |
| | Glucagon Receptor Antagonist I Chemical Properties |
| Boiling point | 517.8±50.0 °C(Predicted) | | density | 1.07±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: soluble | | form | White crystalline solid. | | pka | 13.46±0.40(Predicted) |
| | Glucagon Receptor Antagonist I Usage And Synthesis |
| Description | Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM). It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver. Glucagon receptor antagonist I, at 50 mg/kg, reduces the increase in glucose levels observed after intraperitoneal administration of glucagon in humanized mice. Glucagon receptor antagonist inactive control does not prevent glucagon-mediated actions. |
| | Glucagon Receptor Antagonist I Preparation Products And Raw materials |
|